Sumitomo Mitsui Trust Holdings, Inc. Biogen Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $156 Billion
- Q2 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 414,830 shares of BIIB stock, worth $59 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
414,830
Previous 416,960
0.51%
Holding current value
$59 Million
Previous $57.1 Million
8.69%
% of portfolio
0.03%
Previous 0.04%
Shares
33 transactions
Others Institutions Holding BIIB
# of Institutions
1,022Shares Held
131MCall Options Held
2.84MPut Options Held
2.57M-
Vanguard Group Inc Valley Forge, PA17.3MShares$2.46 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$2.25 Billion1.62% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.07 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.47MShares$1.06 Billion0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.8MShares$683 Million0.11% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $20.5B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...